|
Herbert D. Kleber, M.D.
Professor of
Psychiatry
Director, Division on Substance
Abuse
Dr. Kleber is the Director of the Division on
Substance Abuse at the NYS Psychiatric Institute. He has been in the
substance abuse field for over 35 years and is the author of over
200 scientific articles and books on this subject. Dr. Kleber is an
international expert on the treatment of opiate dependence and is
listed in Best Doctors in America and New York City.
David M. McDowell, M.D.
Director,
Buprenorphine Program
Dr. McDowell is Senior
Medical Director of the Substance Treatment and Research Service of
the NYS Psychiatric Institute and the author of numerous scholarly
and popular articles on psychiatry and substance
abuse.
Erik W. Gunderson,
M.D.
Medical Director, Buprenorphine
Program
Dr. Gunderson trained in internal medicine
at Mt. Sinai Medical Center in New York City where he also served as
Chief Resident. He completed a Substance Abuse Fellowship at
Columbia University College of Physicians and Surgeons and is ABIM
and ASAM certified.
|
